First Ebola virus vaccine to protect human beings?
نویسندگان
چکیده
منابع مشابه
First Ebola virus vaccine to protect human beings?
www.thelancet.com Published online December 22, 2016 http://dx.doi.org/10.1016/S0140-6736(16)32618-6 1 Since the discovery of Ebola virus in 1976, researchers have attempted to develop eff ective vaccines. Early eff orts were largely stalled as a result of the small global market for a vaccine for Ebola virus disease because of an absence of fi nancial incentives for pharmaceutical companies. A...
متن کاملEbola virus-like particles protect from lethal Ebola virus infection.
The filovirus Ebola causes hemorrhagic fever with 70-80% human mortality. High case-fatality rates, as well as known aerosol infectivity, make Ebola virus a potential global health threat and possible biological warfare agent. Development of an effective vaccine for use in natural outbreaks, response to biological attack, and protection of laboratory workers is a higher national priority than e...
متن کاملTowards a vaccine against Ebola virus.
Ebola virus infection causes hemorrhagic fever with high mortality rates in humans and nonhuman primates. Currently, there are no vaccines or therapies approved for human use. Outbreaks of Ebola virus have been infrequent, largely confined to remote locations in Africa and quarantine of sick patients has been effective in controlling epidemics. In the past, this small global market has generate...
متن کاملRecombinant human monoclonal antibodies to Ebola virus.
Human Fab (IgG1kappa) phage display libraries were constructed from bone marrow RNA from 2 donors who recovered from infection with Ebola (EBO) virus during the 1995 outbreak in Kikwit, Democratic Republic of the Congo. The libraries were initially panned against a radiation-inactivated EBO virus-infected Vero cell lysate, but only weak binders were identified. In contrast, panning against secr...
متن کاملCytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection.
Ebolaviruses pose significant public health problems due to their high lethality, unpredictable emergence, and localization to the poorest areas of the world. In addition to implementation of standard public health control procedures, a number of experimental human vaccines are being explored as a further means for outbreak control. Recombinant cytomegalovirus (CMV)-based vectors are a novel va...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet
سال: 2017
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(16)32618-6